Treating ALK-positive non-small cell lung cancer

Targeting genomic alterations, such as epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) gene rearrangements, have radically changed the treatment of patients with non-small cell lung cancer (NSCLC). In the case of ALK-rearranged gene, subsequent rapid developmen...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ann Transl Med
Main Authors: Ziogas, Dimitrios C., Tsiara, Anna, Tsironis, Georgios, Lykka, Maria, Liontos, Michalis, Bamias, Aristotelis, Dimopoulos, Meletios-Athanasios
格式: Artigo
語言:Inglês
出版: AME Publishing Company 2018
主題:
Review Article on Breakthroughs in the Treatment of Advanced Lung Cancer: Making Progress Through Innovation
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5952030/
https://ncbi.nlm.nih.gov/pubmed/29862230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2017.11.34
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍